Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Dorsch U, Csikós J, Blitzer A.

Parkinsonism Relat Disord. 2019 Nov 26;70:23-30. doi: 10.1016/j.parkreldis.2019.11.024. [Epub ahead of print]

PMID:
31794936
2.

IncobotulinumtoxinA Treatment in Upper-Limb Post-Stroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden and Quality of Life.

Marciniak C, Munin MC, Brashear A, Rubin BS, Patel AT, Slawek J, Hanschmann A, Hiersemenzel R, Elovic EP.

PM R. 2019 Oct 24. doi: 10.1002/pmrj.12265. [Epub ahead of print]

PMID:
31647185
3.

Therapy of Sialorrhea with Botulinum Neurotoxin.

Jost WH, Bäumer T, Laskawi R, Slawek J, Spittau B, Steffen A, Winterholler M, Bavikatte G.

Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21. Review.

PMID:
31542879
4.

Statement by a Working Group conceived by the Polish National Consultants in Cardiology and Neurology addressing the use of implantable cardiac monitors in patients after ischaemic embolic stroke of undetermined source.

Farkowski MM, Karliński MA, Kaźmierczak J, Kułakowski P, Mitkowski P, Ptaszyński P, Ryglewicz D, Sławek J, Słowik A, Sterliński M.

Neurol Neurochir Pol. 2019;53(3):181-189. doi: 10.5603/PJNNS.a2019.0018. Epub 2019 May 30.

PMID:
31145466
5.

The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease.

Dulski J, Schinwelski M, Konkel A, Grabowski K, Libionka W, Wąż P, Sitek EJ, Sławek J.

Parkinsonism Relat Disord. 2019 Jul;64:138-144. doi: 10.1016/j.parkreldis.2019.04.001. Epub 2019 Apr 5.

PMID:
30975618
6.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

7.

Editorial Announcement - The Change of Publisher of the Polish Journal of Neurology and Neurosurgery (Neurologia i Neurochirurgia Polska).

Wszolek ZK, Sławek J, Siemiński M.

Neurol Neurochir Pol. 2018 Nov - Dec;52(6):637. doi: 10.1016/j.pjnns.2018.11.001. No abstract available.

PMID:
30553409
8.

A study in a Polish ataxia cohort indicates genetic heterogeneity and points to MTCL1 as a novel candidate gene.

Krygier M, Kwarciany M, Wasilewska K, Pienkowski VM, Krawczyńska N, Zielonka D, Kosińska J, Stawinski P, Rudzińska-Bar M, Boczarska-Jedynak M, Karaszewski B, Limon J, Sławek J, Płoski R, Rydzanicz M.

Clin Genet. 2019 Mar;95(3):415-419. doi: 10.1111/cge.13489. Epub 2019 Jan 8.

PMID:
30548255
9.

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.

Marciniak C, Munin MC, Brashear A, Rubin BS, Patel AT, Slawek J, Hanschmann A, Hiersemenzel R, Elovic EP.

Adv Ther. 2019 Jan;36(1):187-199. doi: 10.1007/s12325-018-0833-7. Epub 2018 Nov 27.

10.

Editorial - The Bibliometric Measurements of the Polish Journal of Neurology and Neurosurgery (Neurologia i Neurochirurgia Polska) for 2017.

Siemiński M, Sławek J, Wszołek Z.

Neurol Neurochir Pol. 2018 Aug;52(4):ii. doi: 10.1016/S0028-3843(18)30304-9. No abstract available.

PMID:
30119779
11.

Functional characterization of a novel progranulin mutation in a patient with progressive nonfluent aphasia.

Gaweda-Walerych K, Sitek EJ, Narożańska E, Wezyk M, Brockhuis B, Zekanowski C, Sławek J.

Neurobiol Aging. 2018 Dec;72:186.e9-186.e12. doi: 10.1016/j.neurobiolaging.2018.06.033. Epub 2018 Jul 2.

PMID:
30057241
12.

The impact of subthalamic deep brain stimulation on polysomnographic sleep pattern in patients with Parkinson's disease - Preliminary report.

Dulski J, Schinwelski M, Konkel A, Grabowski K, Libionka W, Wąż P, E J S, Sławek J.

Neurol Neurochir Pol. 2018 Aug;52(4):514-518. doi: 10.1016/j.pjnns.2018.05.006. Epub 2018 Jun 1.

PMID:
29887129
13.

The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease.

Pierzchlińska A, Białecka M, Kurzawski M, Sławek J.

Neurol Neurochir Pol. 2018 Aug;52(4):477-482. doi: 10.1016/j.pjnns.2018.04.003. Epub 2018 May 5.

PMID:
29776682
14.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

15.

Letter to the Readership of the Polish Journal of Neurology and Neurosurgery.

Wszolek ZK, Slawek J.

Neurol Neurochir Pol. 2018 Mar;52(2):123. doi: 10.1016/j.pjnns.2018.01.002. Epub 2018 Feb 1. No abstract available.

PMID:
29395117
16.

An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtošek Z, Rektorová I, Schlesinger I, Slawek J, Valkovič P, Veselý B.

Parkinsonism Relat Disord. 2018 Apr;49:9-16. doi: 10.1016/j.parkreldis.2017.12.030. Epub 2017 Dec 29. Review.

17.

The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.

Sitek EJ, Wieczorek D, Konkel A, Dąbrowska M, Sławek J.

Psychiatr Pol. 2017 Aug 29;51(4):647-659. doi: 10.12740/PP/OnlineFirst/62804. Epub 2017 Aug 29. English, Polish.

18.

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) - A Polish family with novel SACS mutations.

Krygier M, Konkel A, Schinwelski M, Rydzanicz M, Walczak A, Sildatke-Bauer M, Płoski R, Sławek J.

Neurol Neurochir Pol. 2017 Nov - Dec;51(6):481-485. doi: 10.1016/j.pjnns.2017.08.003. Epub 2017 Aug 17.

PMID:
28843771
19.

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study.

Gajos A, Budrewicz S, Koszewicz M, Bieńkiewicz M, Dąbrowski J, Kuśmierek J, Sławek J, Bogucki A.

J Neural Transm (Vienna). 2017 Nov;124(11):1389-1393. doi: 10.1007/s00702-017-1780-1. Epub 2017 Aug 23.

20.

Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson's Disease.

Sławek J, Madaliński M.

Int Rev Neurobiol. 2017;134:1111-1142. doi: 10.1016/bs.irn.2017.04.012. Epub 2017 Jun 9. Review.

PMID:
28805566
21.

DCTN1-related neurodegeneration: Perry syndrome and beyond.

Konno T, Ross OA, Teive HAG, Sławek J, Dickson DW, Wszolek ZK.

Parkinsonism Relat Disord. 2017 Aug;41:14-24. doi: 10.1016/j.parkreldis.2017.06.004. Epub 2017 Jun 12. Review.

22.

Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts.

Jędrak P, Krygier M, Tońska K, Drozd M, Kaliszewska M, Bartnik E, Sołtan W, Sitek EJ, Stanisławska-Sachadyn A, Limon J, Sławek J, Węgrzyn G, Barańska S.

Metab Brain Dis. 2017 Aug;32(4):1237-1247. doi: 10.1007/s11011-017-0026-0. Epub 2017 May 16.

23.

Restless legs syndrome in adolescents.

Pienczk-Reclawowicz K, Pilarska E, Slawek J.

Brain Dev. 2018 Feb;40(2):163. doi: 10.1016/j.braindev.2017.04.004. Epub 2017 Apr 20. No abstract available.

PMID:
28434768
24.

Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report.

Kłos J, Kwaśniak-Butowska M, Sławek J.

J Neurol Sci. 2017 Apr 15;375:167-169. doi: 10.1016/j.jns.2017.01.068. Epub 2017 Jan 26. No abstract available.

PMID:
28320122
25.

Drawing analysis in the assessment of patients with neurodegenerative diseases.

Sitek EJ, Narożańska E, Konieczna S, Brockhuis B, Wieczorek D, Wszolek ZK, Sławek J.

Neurology. 2017 Jan 10;88(2):218-219. doi: 10.1212/WNL.0000000000003496. No abstract available.

26.

Polyneuropathy in levodopa-treated Parkinson's patients.

Szadejko K, Dziewiatowski K, Szabat K, Robowski P, Schinwelski M, Sitek E, Sławek J.

J Neurol Sci. 2016 Dec 15;371:36-41. doi: 10.1016/j.jns.2016.09.061. Epub 2016 Oct 2.

PMID:
27871444
27.

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.

PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.

28.

Clinical variability of neuroacanthocytosis syndromes-a series of six patients with long follow-up.

Dulski J, Sołtan W, Schinwelski M, Rudzińska M, Wójcik-Pędziwiatr M, Wictor L, Schön F, Puschmann A, Klempíř J, Tilley L, Roth J, Tacik P, Fujioka S, Drozdowski W, Sitek EJ, Wszolek Z, Sławek J.

Clin Neurol Neurosurg. 2016 Aug;147:78-83. doi: 10.1016/j.clineuro.2016.05.028. Epub 2016 Jun 1.

PMID:
27310290
29.

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.

Hauser RA, Slawek J, Barone P, Dohin E, Surmann E, Asgharnejad M, Bauer L.

BMC Neurol. 2016 Jun 7;16:90. doi: 10.1186/s12883-016-0610-7.

30.

Long-Term Follow-Up with Video of a Patient with Deafness-Dystonia Syndrome Treated with DBS-GPi.

Dulski J, Schinwelski M, Mandat T, Pienczk-Ręcławowicz K, Sławek J.

Stereotact Funct Neurosurg. 2016;94(2):123-5. doi: 10.1159/000445078. Epub 2016 Apr 22.

PMID:
27100856
31.

New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death.

Gorska M, Kuban-Jankowska A, Slawek J, Wozniak M.

Curr Med Chem. 2016;23(15):1513-27. Review.

PMID:
26980569
32.

A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.

Dąbrowska M, Drabarek T, Muraszko-Klaudel A, Sławek J.

Neurol Neurochir Pol. 2015;49(6):460-6. doi: 10.1016/j.pjnns.2015.09.005. Epub 2015 Sep 19. Review.

PMID:
26652884
33.

The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.

Dąbrowska M, Schinwelski M, Sitek EJ, Muraszko-Klaudel A, Brockhuis B, Jamrozik Z, Sławek J.

Neurol Neurochir Pol. 2015;49(6):421-31. doi: 10.1016/j.pjnns.2015.10.002. Epub 2015 Oct 23. Review.

PMID:
26652877
34.

Erratum to: Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):259. doi: 10.1007/s00702-015-1471-8. No abstract available.

PMID:
26546035
35.

Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):251-8. doi: 10.1007/s00702-015-1453-x. Epub 2015 Sep 14. Erratum in: J Neural Transm (Vienna). 2016 Mar;123(3):259.

PMID:
26370676
36.

Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer's disease and mild cognitive impairment?

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Barcikowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(4):239-44. doi: 10.1016/j.pjnns.2015.06.001. Epub 2015 Jun 17.

PMID:
26188940
37.

Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Narożańska E, Konkel A, Dąbrowska M, Barcikowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(4):217-22. doi: 10.1016/j.pjnns.2015.05.004. Epub 2015 Jun 6.

PMID:
26188937
38.

Art and dystonia.

Garcia-Ruiz PJ, Slawek J, Sitek EJ, Martinez Castrillo JC.

J Neurol Sci. 2015 Sep 15;356(1-2):49-54. doi: 10.1016/j.jns.2015.06.049. Epub 2015 Jun 25. Review.

PMID:
26139341
39.

Genomic instability in the PARK2 locus is associated with Parkinson's disease.

Ambroziak W, Koziorowski D, Duszyc K, Górka-Skoczylas P, Potulska-Chromik A, Sławek J, Hoffman-Zacharska D.

J Appl Genet. 2015 Nov;56(4):451-461. doi: 10.1007/s13353-015-0282-9. Epub 2015 Apr 2.

40.

Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.

Sitek EJ, Konkel A, Dąbrowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(1):36-40. doi: 10.1016/j.pjnns.2014.12.002. Epub 2014 Dec 9.

PMID:
25666771
41.

Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation--a 5 year follow up.

Schinwelski M, Kierdaszuk B, Dulski J, Tońska K, Kodroń A, Sitek EJ, Bartnik E, Kamińska A, Kwieciński H, Sławek J.

Metab Brain Dis. 2015 Aug;30(4):1083-5. doi: 10.1007/s11011-014-9645-x. Epub 2014 Dec 31.

42.

Neuroimaging in the differential diagnosis of primary progressive aphasia - illustrative case series in the light of new diagnostic criteria.

Sitek EJ, Narożańska E, Brockhuis B, Muraszko-Klaudel A, Lass P, Harciarek M, Sławek J.

Pol J Radiol. 2014 Aug 8;79:251-8. doi: 10.12659/PJR.890320. eCollection 2014.

43.

Saccadic eye movements in juvenile variant of Huntington disease.

Grabska N, Rudzińska M, Wójcik-Pędziwiatr M, Michalski M, Sławek J, Szczudlik A.

Neurol Neurochir Pol. 2014;48(4):236-41. doi: 10.1016/j.pjnns.2014.06.003. Epub 2014 Jun 27.

PMID:
25168321
44.

Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection.

Narożańska E, Białecka M, Adamiak-Giera U, Gawrońska-Szklarz B, Sołtan W, Schinwelski M, Robowski P, Madaliński MH, Sławek J.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):96-9. doi: 10.1097/WNF.0000000000000037.

PMID:
24992088
45.

The neurosurgical treatment of patients in dystonic state - overview of the literature.

Sobstyl MR, Sławek JW, Ząbek M.

Neurol Neurochir Pol. 2014 Jan-Feb;48(1):63-70. doi: 10.1016/j.pjnns.2013.04.002. Epub 2014 Jan 23. Review.

PMID:
24636773
46.

BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Mak M, Deptuła-Jarosz M, Gołąb-Janowska M, Droździk M, Sławek J.

Neurosci Lett. 2014 Feb 21;561:86-90. doi: 10.1016/j.neulet.2013.12.051. Epub 2014 Jan 3.

PMID:
24394906
47.

[Homocysteine and its role in pathogenesis of Parkinson's disease and other neurodegenerative disorders].

Szadejko K, Szabat K, Ludwichowska A, Sławek J.

Przegl Lek. 2013;70(7):443-7. Review. Polish.

PMID:
24167945
48.

ENNET: inferring large gene regulatory networks from expression data using gradient boosting.

Sławek J, Arodź T.

BMC Syst Biol. 2013 Oct 22;7:106. doi: 10.1186/1752-0509-7-106.

49.

Hemiparkinsonism-hemiatrophy syndrome - report on two cases and review of the literature.

Dziadkiewicz A, Białecka M, Janik P, Sławek J.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):387-92. Review.

PMID:
23986429
50.

Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.

Koziorowski D, Hoffman-Zacharska D, Sławek J, Jamrozik Z, Janik P, Potulska-Chromik A, Roszmann A, Tataj R, Bal J, Friedman A.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):319-24.

PMID:
23986421

Supplemental Content

Loading ...
Support Center